HIV Vaccine/Development

New Vaccine Hoped Effective Against Changes in Virus

Published in Vaccine Weekly, September 4th, 1995

According to an article in the August 11, 1995, Vanderbilt University Medical Center (VUMC) Reporter, a new vaccine researchers hope will produce an effective cellular immunity against HIV is a radically different approach from past vaccines, said a Vanderbilt University Medical Center (VUMC) physician.

The genetically engineered vaccine induces "killer" T cells - in addition to anti-HIV antibodies - that should be more effective against the constantly changing HIV, said Dr. Paul Spearman, assistant professor of Pediatrics and principal investigator in the trial.

The novel vaccine is called p17/p24:Ty-VLP.

"I would like to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-09-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry